Mylan Pharmaceuticals is facing two lawsuits relating to its pricing of EpiPentreatments for life-threatening anaphylactic shock.
One suit, filed Tuesday in an Ohio county court, alleges that the company's price increases — which brought the list price up to about $600 for two EpiPens — violated the state's consumer protection law.
Read Full Article »